1Poser CM,Paty DW,Scheinberg L,et al.New diagnostic criteria for multiple sclerosis:guidelines for research protocols.Ann Neurol,1983,13:2273
2Hooper DC,Scott GS,Zborek A,et al.Uric acid,a peroxynitrite scavenger,inhibits CNS inflammation,blood-CNS barrier permeability changes,and tissue damage in a mouse model of multiple sclerosis.FASEB J,2000,14:691
3Touil T,Deloire-Grassin MS,Vital C,et al.In vivo damage of CNS myelin and axons induced by peroxynitrite.Neuroreport,2001,12:3637
4Toncev G,Milicic B,Toncev S,et al.Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction.Eur J Neurol,2002,9:221
5Drulovic J,Dujmovic I,Stojsavljevic N,et al.Uric acid levels in sera from patients with multiple sclerosis.J Neurol,2001,248:121
6Spitsin S,Hooper DC,Leist T,et al.Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease.Mult Scler,2001,7:313
8Keles MS,Taysi S,Aksoy H,et al.The effect of corticosteroids on serum and cerebrospinal fluid nitric oxide levels in multiple sclerosis.Clin Chen Lab Med,2001,39:827
9Rosenberg GA,Dencoff JE,Correa N Jr,et al.Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis:relation to blood-brain barrier injury.Neurology,1996,46:1626
10Koprowski H,Spitisin SV,Hooper DC,et al.Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid,a scavenger of peroxynitrite.Ann Neurol,2001,49:139
8De Lau LM, Koudstaal PL, Hofma NA,et al. Serum uric acid levels and the risk of Parkinson's disease[J]. Ann Neutol, 2005,58(5) 797 - 800.
9Weisskopf MG, Oreillye, Chen H, et al. Plasma urate and risk of Parkinson's disease[J]. Am J Epidemisl,2007,166(5) :561 - 567.
10Schenkman ML, Clark K, Xie T, et al. Spinal movement and per formance of a standing reach task in participants with and without Parkinson disease[J]. Phys Ther,2001,81 :1400 - 1411.
